Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Silverman

Showing results (661-670 of 816) with videos related to

Pageof 82
Sort By:
Pediatric Blood & Cancer|July 9, 2013
Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01Deborah P Waber, Marie McCabe, Mikaela Sebree, et al.
Leukemia|January 4, 2024
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium ProtocolsYannis K Valtis, Yael Flamand, Shai Shimony, et al.
ACS Chemical Biology|April 17, 2024
Design, Synthesis, and Mechanistic Studies of (<i>R</i>)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine AminotransferaseAllison N Devitt, Abigail L Vargas, Wei Zhu, et al.
ACS Chemical Biology|July 18, 2024
Correction to "Design, Synthesis, and Mechanistic Studies of (<i>R</i>)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase"Allison N Devitt, Abigail L Vargas, Wei Zhu, et al.
Experimental Hematology|February 26, 2005
Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemiaW Nicholas Haining, Angelo A Cardoso, Heather L Keczkemethy, et al.
Cell Reports|December 4, 2012
The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse modelsVanita Chopra, Luisa Quinti, Jinho Kim, et al.
Journal of the American Chemical Society|April 21, 2018
β-Glucocerebrosidase Modulators Promote Dimerization of β-Glucocerebrosidase and Reveal an Allosteric Binding SiteJianbin Zheng, Long Chen, Owen S Skinner, et al.
Journal of the American Chemical Society|March 16, 2022
Rational Design, Synthesis, and Mechanism of (3<i>S</i>,4<i>R</i>)-3-Amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic Acid: Employing a Second-Deprotonation Strategy for Selectivity of Human Ornithine Aminotransferase over GABA AminotransferaseWei Zhu, Arseniy Butrin, Rafael D Melani, et al.
Cancer Cell|November 4, 2008
H3K79 methylation profiles define murine and human MLL-AF4 leukemiasAndrei V Krivtsov, Zhaohui Feng, Madeleine E Lemieux, et al.
American Journal of Hematology|September 18, 2007
Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1Scott J Rodig, Ethan G Payne, Barbara A Degar, et al.
Pageof 82

Showing results (661-670 of 816) with videos related to

Sort By:
Pageof 82
Pediatric Blood & Cancer|July 9, 2013
Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01Deborah P Waber, Marie McCabe, Mikaela Sebree, et al.
Leukemia|January 4, 2024
Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium ProtocolsYannis K Valtis, Yael Flamand, Shai Shimony, et al.
ACS Chemical Biology|April 17, 2024
Design, Synthesis, and Mechanistic Studies of (<i>R</i>)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine AminotransferaseAllison N Devitt, Abigail L Vargas, Wei Zhu, et al.
ACS Chemical Biology|July 18, 2024
Correction to "Design, Synthesis, and Mechanistic Studies of (<i>R</i>)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase"Allison N Devitt, Abigail L Vargas, Wei Zhu, et al.
Experimental Hematology|February 26, 2005
Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemiaW Nicholas Haining, Angelo A Cardoso, Heather L Keczkemethy, et al.
Cell Reports|December 4, 2012
The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse modelsVanita Chopra, Luisa Quinti, Jinho Kim, et al.
Journal of the American Chemical Society|April 21, 2018
β-Glucocerebrosidase Modulators Promote Dimerization of β-Glucocerebrosidase and Reveal an Allosteric Binding SiteJianbin Zheng, Long Chen, Owen S Skinner, et al.
Journal of the American Chemical Society|March 16, 2022
Rational Design, Synthesis, and Mechanism of (3<i>S</i>,4<i>R</i>)-3-Amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic Acid: Employing a Second-Deprotonation Strategy for Selectivity of Human Ornithine Aminotransferase over GABA AminotransferaseWei Zhu, Arseniy Butrin, Rafael D Melani, et al.
Cancer Cell|November 4, 2008
H3K79 methylation profiles define murine and human MLL-AF4 leukemiasAndrei V Krivtsov, Zhaohui Feng, Madeleine E Lemieux, et al.
American Journal of Hematology|September 18, 2007
Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1Scott J Rodig, Ethan G Payne, Barbara A Degar, et al.
Pageof 82